The FDA hit a Farmingdale, New York generic drugmaker with a Form 483 for a large number of violations, including inadequate complaint investigations and multiple issues with testing. Read More

Pfizer, Eli Lilly and Merck are allowing their employees who are licensed medical professionals to volunteer in COVID-19 medical efforts. Read More

Drugmakers are scouring their product portfolios for possible COVID-19 treatments and some are showing potential. Read More

The FDA is promoting a nationwide effort to investigate two blood-based therapies for treatment of COVID-19. Read More

The anti-malaria drug hydroxychloroquine was effective in treating COVID-19 patients in China, according to early data from a small clinical trial. Read More

Philip Morris and British American Tobacco (BAT) have entered the race for a COVID-19 vaccine in collaboration with two biotech firms working on plant-based vaccines. Read More

Pharma giant Pfizer was taken to task in an FDA warning letter over testing violations at its Visakhapatnam, Andhra Pradesh sterile injectable drug facility. Read More

Novartis and Aurobindo have terminated their $1 billion deal to sell the Sandoz U.S. generic oral solids and dermatology business to Aurobindo. Read More